Skip to main content


Table 2 Financial implications for ‘A Country’ in preventing hospitalisations due to adverse drug reactions

From: Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence

Annual number of hospital admissions 500,000
No. of admissions at a 4 -6% ADR incidence level 20,000 - 30,000
At an average length of stay of 5 days 100,000 – 150,000
At an average cost of £300/day £30 m - £45 m
Potential savings (based on 50%-70% preventability) £15 m - £31.5 m
  1. (NB Average length of stay and daily costs will be country specific).